my aprevo® vs GAiTEWAY
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
my aprevo®
This app allows surgeons and healthcare professionals to review patient-specific implant designs for surgical planning. It utilizes patient data and proprietary technology to create personalized spine fusion devices, aiming to improve surgical outcomes and reduce healthcare costs.
- Review surgical plans
- Patient-specific implant designs
- Personalized spine fusion devices
- Utilizes patient data
- Proprietary digital technologies
Read full descriptionHide full description
The my aprevo® mobile app enables surgeons and healthcare professionals to review surgical plans with proposed patient-specific implant designs. Carlsmed, Inc. was founded in 2018 with the mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. The company’s aprevo® devices are personalized to improve the standard of care for the surgical treatment of adults with spinal malalignment. Carlsmed uses patient data and proprietary digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices to align with the surgeon’s goals for each patient.
GAiTEWAY
Read full descriptionHide full description
The GAiTEWAY™ mobile application provides access to the data collected in the GAiTEWAY™ software platform to view imaging and clinical data for spine patients. The platform provides a means to visualize pre-operative images, measurements, surgical plans, and order patient-specific spine rods. The platform also serves to facilitate communication between users and internal Medtronic stakeholders.
Screenshots
Verdict
my aprevo® and GAiTEWAY are too close to call on the numbers: across 6 compared parameters — price, update cadence, ads and in-app purchases among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Both ship on a similar rhythm, roughly fortnightly. The most recent releases landed on September 24, 2026 and September 4, 2026 respectively.
| Parameter | my aprevo® | GAiTEWAY |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (16 ratings) — better | — |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 16 — better | — |
| Update frequency | Fortnightly | Fortnightly |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad — better | iPhone |
| Requires iOS | 17.0 — better | 18.0 |
| Further details — not scored | ||
| Size | 120 MB | 18 MB |
| Age rating | 4+ | 17+ |
| Developer | Carlsmed, Inc. | Medtronic, Inc. |
In-app purchases
my aprevo®
No in-app purchases
GAiTEWAY
No in-app purchases
Questions
Is my aprevo® free?
Is GAiTEWAY free?
Do my aprevo® or GAiTEWAY have ads?
Which is updated more often, my aprevo® or GAiTEWAY?
Other comparisons
